A phase I study of oral uracil/ftorafur (UFT) plus leukovorin in combination with weekly paclitaxel (P) in patients (pts) with solid tumors.

被引：0
|
作者：
Mayer, F
von Pawel, J
Beck, J
Schroeder, M
Hartmann, JT
Kanz, L
Bokemeyer, C
机构：
[1] St Johannes Hosp, Duisburg, Germany
[2] Univ Mainz, D-6500 Mainz, Germany
[3] Asklepios Fachklin Munchen Gauling, Munich, Germany
[4] Univ Tubingen, Med Ctr, Dept Hematol Oncol, Tubingen, Germany
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
620P
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [41] A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
    O'Brien, Mary E. R.
    Sarker, Debashis
    Bhosle, Jaishree
    Thillai, Kiruthikah
    Yap, Timothy A.
    Uttenreuther-Fischer, Martina
    Pemberton, Karine
    Jin, Xidong
    Wiebe, Sabrina
    de Bono, Johann
    Spicer, James
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 757 - 766
  • [42] A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
    Mary E. R. O’Brien
    Debashis Sarker
    Jaishree Bhosle
    Kiruthikah Thillai
    Timothy A. Yap
    Martina Uttenreuther-Fischer
    Karine Pemberton
    Xidong Jin
    Sabrina Wiebe
    Johann de Bono
    James Spicer
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 757 - 766
  • [43] A phase I study of ARQ 197 in combination with temsirolimus in patients (Pts) with advanced stolid tumors.
    Braden, Amy M.
    Wisinski, Kari Braun
    Eickhoff, Jane C.
    Schelman, William R.
    Bailey, Howard Harry
    Mulkerin, Daniel
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors
    Sandler, A
    Raghavan, D
    Meropol, N
    Meyers, T
    Kindler, H
    Fox, S
    Perez, R
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1120 - 1120
  • [45] Phase I trial of CT-2106 (polyglutamated camptothecin) administered weekly in patients (pts) with advanced solid tumors.
    Daud, A.
    Garrett, C.
    Simon, G. R.
    Munster, P.
    Sullivan, D.
    Stromatt, S.
    Allevi, C.
    Bernareggi, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 82S - 82S
  • [46] A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Thompson, Dana S.
    Mohyuddin, Adil
    Bendell, Johanna C.
    Yardley, Denise A.
    Burris, Howard A., III
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (03) : 471 - 475
  • [47] A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors
    Suzanne F. Jones
    Jeffrey R. Infante
    Dana S. Thompson
    Adil Mohyuddin
    Johanna C. Bendell
    Denise A. Yardley
    Howard A. Burris
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 471 - 475
  • [48] Phase I clinical trial of daily imatinab mesylate (Gleevec) and weekly Paclitaxel in patients with advanced refractory solid tumors.
    Bahrani, A
    Hwang, J
    Egorm, MJ
    Barmen, P
    Ramzi, P
    Marshall, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6252S - 6252S
  • [49] Phase I dose-finding study of trabectedin (T) in combination with cisplatin (C) in patients (pts) with advanced solid tumors.
    Sessa, C.
    Gallerani, E.
    Del Conte, G.
    Christinat, A.
    Perotti, A.
    Lardelli, P.
    Kahatt, C. M.
    Florez, A.
    Fernandez, C.
    Miani, M.
    Gianni, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Phase I study of weekly docetaxel and topotecan in the treatment of advanced solid tumors.
    Tan, BR
    Read, W
    Bergeron, K
    Fracasso, PM
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
12345